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Recent publications have proposed that aging should be classified as a disease (Bulterijs et al., 2015;
Zhavoronkov and Bhullar, 2015; Zhavoronkov and Moskalev, 2016). The goal of this manuscript
is not to dispute these claims, but rather to suggest that when classifying aging as a disease, it is
important to include the contribution of microbes.
As recently as ∼115 years ago, more than half of all deaths were caused by infectious diseases,
including pneumonia, influenza, tuberculosis, gastrointestinal infections, and diphtheria (Jones
et al., 2012). Since then, the establishment of public health departments that focused on improved
sanitation and hygiene, and the introduction of antibiotics and vaccines allowed for a dramatic
decrease in infectious disease-related mortality (Report, 1999). In 2010, the death rate for infectious
diseases was reduced to 3% (Jones et al., 2012). Simultaneously, as infectious disease-related
mortality rates have decreased, global lifespan has increased from∼30 to∼70 years (Riley, 2005).
Because death rates due to infectious diseases have been reduced to very low levels, we’ve
forgotten about the adverse effects of microbes on our existence. The fact is, we live in a microbial
world. Although there are currently∼7 billion people, in contrast, the total number of prokaryotes
and viruses have been estimated at 1030 and 1031, respectively (Whitman et al., 1998; Duerkop et al.,
2014). Even without including other microbes (e.g., fungi, protozoa), humans are outnumbered by
more than 1021 to 1! All of these microorganisms aren’t detrimental to human health, but more
than 1400 microbial species have been shown to be pathogenic (Taylor et al., 2001).
Even at a young chronological age, microbes find their way into the blood and tissues.
Circulating microbial DNA is found in young, healthy adults (average age, BMI: 21 years
< 25 kg/m2) (Païsse et al., 2016). Interestingly, levels of circulating bacterial DNA were not
homogeneous: some subjects had 3-fold or more circulating bacterial DNA when compared with
others. Moreover, various bacterial species are found in skeletal muscle, heart, liver, adipose tissue,
and in the brains of young mice (Lluch et al., 2015).
With the passage of time, the barriers responsible for keeping microbes out of us weaken. For
example, tight junctions (TJs) connect epithelial cells, thereby minimizing the space in between the
cells, and minimizing the ability of microbes to translocate into the blood. TJs are comprised of
proteins such as junctional adhesion molecule (JAM), zonulin (e.g., ZO-1), occludins, and claudin.
Bacteria and viruses, including Vibrio cholera, Shigella, and rotavirus have evolved mechanisms to
impair TJ assembly: V. cholera uses a cleavage product from the ZOT protein to dissociate ZO-1
from the cell periphery, ZO-1 binds to the actin-containing tail of Shigella, thereby disrupting
the TJ, and rotavirus uses the VP8 fragment of VP4 to dissociate claudin, occludin, and ZO-1
(Guttman and Finlay, 2009). Whether caused by pathogenic microbes or because of defects in
host gene expression, levels of many of these tight junction proteins, including JAM-A, ZO-1,
and occludin are decreased in old, when compared with young (Tran and Greenwood-Van
Meerveld, 2013). Furthermore, although the immune system should protect us against an increase
in microbial burden, however, many aspects of the immune response are decreased, whereas others
are increased, thereby resulting in dysregulation. This phenotype is known as immunosenescence
(Pera et al., 2015). Interestingly, a causative role for microbes on reducing immune function is
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suggested by the finding that young adults infected with
cytomegalovirus (CMV) exhibit signs of immunosenescence
(Turner et al., 2014).
The impact of decreased barrier function and
immunosenescence would be expected to lead to an increase
in circulating microbes in old, when compared with young.
Although circulating levels of bacterial DNA have yet to be
reported in older adults, plasma levels of lipopolysaccharide
(LPS), which is found in the outer membrane of gram-negative
bacteria, and levels of the receptors that bind to LPS (TLR4)
and to bacterial flagellin (TLR5), are elevated in older adults,
when compared with young (Qian et al., 2012; Ghosh et al.,
2015). In line with this, the incidence of bloodstream infections
with LPS-containing Escherichia coli is increased by more than
10-fold in adults older than 74, when compared with subjects
younger than 50 years (Williamson et al., 2013). Similarly, the
incidence of bloodstream infections with gram-positive bacteria
(Staphylococcus aureus) is elevated by more than 8–17 fold in
older adults (Klevens et al., 2007).
What are the consequences of an age-related increase in
microbial burden? Microbes and/or microbial products are
causatively involved in multiple theories of aging, including
insulin resistance, oxidative stress, inflammation, and telomere
shortening. In support of this, LPS injection into young, healthy
subjects (average age, BMI: 26 years, < 25 kg/m2) causes
insulin resistance, as determined by elevated HOMA-IR values
(Mehta et al., 2010). Oxidative stress is increased in response
to the binding of LPS and bacterial flagellin to their respective
receptors (Yuan et al., 2013; Kim et al., 2016). Levels of the
pro-inflammatory cytokines IL-6 and TNF-α are increased when
LPS binds to TLR4 (Greenhill et al., 2011). Telomere shortening
occurs at a faster rate in the presence of CMV infection (Parry
et al., 2016). Interestingly, the prevalence of CMV infection
increases from ∼20% in adults younger than 50 years, to ∼40%
in 50–70 year olds, to 100% in adults older than 70 (Parry
et al., 2016). Collectively, these data support a causative role
for microbial burden on mechanisms that have been commonly
hypothesized to drive the aging process.
Microbial burden is also involved in mechanisms related
to age-related disease, including cardiovascular disease (CVD),
Alzheimer’s disease, cancer, stroke, and diabetes. In support of
this, approximately 10-fold more circulating bacterial DNA is
found in CVD patients, when compared with healthy controls
(Dinakaran et al., 2014). Oral and gut microbes are found
within atherosclerotic plaque (Koren et al., 2011). A causative
role for bacteria on cardiovascular disease is supported by the
finding that the oral microbe, Porphyromonas gingivalis, causes
atherosclerotic plaque formation (Velsko et al., 2014).
Moreover, many of the molecular players related to
atherosclerotic plaque formation, including C-reactive protein
(CRP), LDL cholesterol, and fibrinogen (Spronk et al., 2004),
are protective against infection-related mortality. For example,
although injection of Streptococcus pneumonae kills 80% of wild
type mice within 2 days, survival is improved by more than
4-fold in the presence of CRP (Mold et al., 2002). Similarly,
although infection with Klebsiella pneumoniae kills all wild
type mice within 2 days, survival is significantly improved in
mice that are genetically engineered to have elevated circulating
levels of LDL cholesterol (Netea et al., 1996). Interestingly, LDL
acts as a carrier for LPS (Levels et al., 2005), and is involved
in mechanisms that inactivate LPS (Weinstock et al., 1992).
Approximately half of all fibrinogen-deficient mice that are
injected with S. aureus die within 12 days, whereas mice that
have wild type levels of fibrinogen are protected (Prasad et al.,
2015). In addition, fibrinogen levels are significantly correlated
with the amount of bacteria found in blood (Amar et al., 2011).
CRP, LDL, and fibrinogen increase during aging (Abbott et al.,
1983; Kannel et al., 1987; Herman et al., 2009), findings that
support a link between microbial burden with the progression of
CVD.
Patients with Alzheimer’s disease (AD) have an increased
amount of circulating bacteria (spirochaetes) when compared
with age-matched, AD-free controls (Miklossy, 1993). Four-fold
more Treponema bacteria, 3-fold more herpes simplex virus type
I DNA, and fungi, including Candida albicans and Sacharomyces
cerevisiae have been found in the brains of AD patients, when
compared with age-matched controls (Riviere et al., 2002;
Wozniak et al., 2009; Pisa et al., 2015). Further support for the
hypothesis that Alzheimer’s disease has a microbial component
comes from the finding that β-amyloid protein (Aβ), which is a
key mediator of AD pathology, is an antimicrobial peptide. Aβ
inhibits the growth of various fungi and bacteria, when compared
against the well-known anti-microbial peptide, LL-37 (Soscia
et al., 2010). In addition, levels of another antimicrobial peptide,
β-defensin-1, are elevated in AD brains, when compared with
age-matched controls (Williams et al., 2013). These data suggest
that the increased prevalence of Aβ and β-defensin-1 that are
found in the brains of AD patients may be a compensatory
mechanism to protect the brain against microbial infection.
A role for microbial burden on cancer incidence is supported
by the findings that liver tumor amounts and tumor size
are significantly increased in the presence of LPS (Dapito
et al., 2012), and that exposure to LPS causes pancreatic
cancer. Mice treated with LPS develop significantly more
advanced pancreatic intraepithelial neoplasias, when compared
with untreated controls (Ochi et al., 2012). Beyond LPS, bacteria,
viruses, and parasites are associated with or are causatively
involved with the progression of various cancers, including H.
pylori with stomach cancer, the hepatitis B and C viruses with
liver cancer, the human papillomavirus virus (HPV) with cervical
cancer, and the parasite Schistosoma haematobium with bladder
cancer (de Martel et al., 2012).
In terms of cerebrovascular disease (stroke), a circulating
microbial index comprised of 2 bacterial (Chlamydophila
pneumoniae, H. pylori) and 3 viral (CMV, herpes simplex virus
1 and 2) species was associated with a 40% increased risk
of stroke (Elkind et al., 2010). Furthermore, various bacteria,
parasites, fungi, and viruses, including H. pylori, Trypanosoma
cruzi, Asperigillus, CMV, and others have been implicated in
stroke pathogenesis (Miller and Elkind, 2016). One way that
microbial burden may contribute to stroke risk is by the binding
of LPS to fibrinogen. Within 10 min of exposure of fibrinogen
to LPS, fibrils and dense, matted deposits are formed (Pretorius
et al., 2016). Similarly, the addition of LPS to whole blood results
Frontiers in Genetics | www.frontiersin.org 2 December 2016 | Volume 7 | Article 212
Lustgarten The Microbial Contribution to Aging
in amyloid-like matted deposits and a hypercoagulated state (i.e.,
blood clots), evidence that provides a link between circulating
microbial burden with stroke.
In addition to LPS’s causative role on insulin resistance,
elevated circulating LPS is associated with a significantly higher
risk for the development of type 2 diabetes in middle-aged adults
(Pussinen et al., 2011). LPS may not be the only bacterial trigger
for inducing insulin resistance. In support of this, blood levels of
bacterial DNA are elevated in middle-aged, and in older adults
with type II diabetes, when compared with healthy controls
(Amar et al., 2011; Sato et al., 2014).
If we are fortunate to avoid these diseases and live to achieve
centenarian status, infectious disease as a major cause of death
arises again. In Japan, more than 40% of all centenarian deaths
are due infectious diseases, including pneumonia (Tauchi et al.,
1999). Similarly, in a larger study of ∼36,000 centenarians from
the UK, other than “old age,” the leading cause of death was
pneumonia (Evans et al., 2014). In short, over the past 115+
years, we haven’t eliminated the adverse effects of microbes on
our health, we’ve merely delayed them!
As an argument against the role of microbes on causing
many aspects of aging and age-related disease, it is important
to note that host aging does indeed occur in their absence.
Although lifespan in microbe-free mice is increased by 20–50%
(Gordon et al., 1966; Tazume et al., 1991), these animals are not
immortal. Nonetheless, as presented here, microbes are involved
in mechanisms related to aging and age-related disease, and
accordingly, I posit that any classification of aging as a disease
should include the contribution of microbes.
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